Indian J Med Microbiol Close
 

Figure 2: Comparative results of RCTs by Antonelli et al. and Hilbert et al. on immunosuppressed AHRF patients showing differences in the rate of ETI, fatal complications, and mortality in patients when treated with UMC and UMC + NIV

Figure 2: Comparative results of RCTs by Antonelli <i>et al.</i> and Hilbert et al. on immunosuppressed AHRF patients showing differences in the rate of ETI, fatal complications, and mortality in patients when treated with UMC and UMC + NIV